Showing results (1821-1830 of 1,933) with videos related to

Sort By:
Pageof 194
Acta Oncologica (Stockholm, Sweden)|September 14, 2020
Health-related quality of life of long-term advanced melanoma survivors treated with anti-CTLA-4 immune checkpoint inhibition compared to matched controlsA H Boekhout, A Rogiers, K Jozwiak, et al.
Nature Communications|February 14, 2024
Gene-expression-based T-Cell-to-Stroma Enrichment (TSE) score predicts response to immune checkpoint inhibitors in urothelial cancerMaud Rijnders, J Alberto Nakauma-González, Debbie G J Robbrecht, et al.
Blood Advances|October 6, 2019
Identification of a tumor-specific allo-HLA-restricted γδTCRG J J Kierkels, W Scheper, A D Meringa, et al.
Clinical Nuclear Medicine|December 19, 2023
The Predictive Value of FDG PET/CT for Determining Progression-Free Survival in Advanced Stage III-IV BRAF -Mutated Melanoma Patients Treated With Targeted Therapy-What Can Be Learned From Progression?Bernies van der Hiel, Else A Aalbersberg, Alfons J M van den Eertwegh, et al.
Blood Advances|January 26, 2021
Neutrophil specific granule and NETosis defects in gray platelet syndromeCathelijn E M Aarts, Kate Downes, Arie J Hoogendijk, et al.
Cancer Immunology, Immunotherapy : CII|March 28, 2021
Clinical outcome of patients with metastatic melanoma of unknown primary in the era of novel therapyDanielle Verver, Dirk J Grünhagen, Alexander C J van Akkooi, et al.
JAMA Network Open|October 16, 2024
Upper- vs Lower-Extremity Secondary Access During Transcatheter Aortic Valve Implantation: A Randomized Clinical TrialGeert A A Versteeg, Maxim J P Rooijakkers, Kimberley I Hemelrijk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2013
Primary granulocyte colony-stimulating factor prophylaxis during the first two cycles only or throughout all chemotherapy cycles in patients with breast cancer at risk for febrile neutropeniaMaureen J Aarts, Frank P Peters, Caroline M Mandigers, et al.
ESMO Gastrointestinal Oncology|March 11, 2026
Preference versus protocol: oncology clinicians' perspectives on central venous access for administration of chemotherapy in pancreatic cancerM U J E Graus, R A L Willems, N C Biesma, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|April 23, 2024
Upper extremity versus lower extremity for secondary access during transcatheter aortic valve implantation: rationale and design of the randomised TAVI XS trialMaxim J P Rooijakkers, Geert A A Versteeg, Kimberley I Hemelrijk, et al.
Pageof 194